Key Notes on Chest Pain Types and Management

Imbalance in Myocardial Oxygen Supply and Demand

  • Characterized by stable angina or acute coronary syndrome.
  • Vascular smooth muscle spasms can impair cardiac blood flow, leading to ischemia and angina.
  • Patients with Ischemic Heart Disease (IHD) and angina need EBG directed therapies, which include lifestyle changes and risk factor management.

Types of Chest Pain

Stable Angina
  • Also known as Effort Induced Angina, Classic or Typical Angina.
  • Symptoms typically include a short-acting, burning, heavy, or squeezing sensation.
  • Some episodes can present with atypical symptoms such as fatigue, nausea, or sweating. Atypical presentations are common in women, diabetics, and older adults.
  • Usually caused by fixed obstruction of a coronary artery due to plaque.
  • Ischemia may be induced by activity but is relieved by rest or Nitroglycerin (NTG).
  • The pattern of chest pain (CP) remains consistent over time, hence labeled as 'stable'.
Unstable Angina
  • CP that increases in frequency and intensity with less effort.
  • Episodes lasting longer than 20 minutes, new onset angina or increasing angina, or sudden shortness of breath (SOB) are red flags for unstable angina.
  • Symptoms are not relieved by rest or NTG, indicating a form of acute coronary syndrome requiring hospitalization and aggressive treatment.
Prinzmetal Angina (Variant Angina)
  • Uncommon type of angina occurring at rest due to spasm of coronary arteries.
  • Not linked to physical activity or stress.
  • Responds well to coronary vasodilators such as NTG and Calcium Channel Blockers (CCBs).
Acute Coronary Syndrome
  • Emergency situation, often due to plaque rupture leading to partial or complete thrombosis of a coronary artery.
  • If untreated, can lead to myocardial necrosis (Myocardial Infarction - MI).

Drug Therapy for Chest Pain

  • Four classes of drugs are commonly prescribed:
    • Beta-Blockers (BBs)
    • Calcium Channel Blockers (CCBs)
    • Organic Nitrates
    • Sodium Channel Blockers (Ranolazine)
Concomitant Diseases and Drug Commonality
  • No Concurrent Conditions: Long-acting nitrate, Beta-Blockers.
  • Recent Myocardial Infarction: Long-acting nitrate, Beta-Blockers.
  • Asthma, COPD: Long-acting nitrate.
  • Hypertension: Long-acting nitrate, Beta-Blockers.
  • Diabetes: Long-acting nitrate.
  • Chronic Renal Disease: Long-acting nitrate, Beta-Blockers, and Calcium Channel Blockers.
Beta Blockers
  • Reduce myocardial oxygen demand by blocking beta-1 receptors, which decreases heart rate (HR), contractility, cardiac output (CO), and blood pressure (BP).
  • Effective in increasing exercise duration and tolerance in patients with stable angina.
  • First-line treatment for angina, but not for Prinzmetal angina as they can worsen symptoms.
  • Should not be used in severe bradycardia and must be tapered off to prevent complications.
Calcium Channel Blockers
  • Block the entrance of calcium into cardiac and vascular smooth muscle cells.
  • Two types: Dihydropyridines (e.g., Amlodipine) affecting peripheral smooth muscles and non-dihydropyridines (e.g., Verapamil, Diltiazem) affecting the heart.
    • Amlodipine: Minimal effects on cardiac function, useful for variant angina.
    • Verapamil: Slows AV conduction, not advised for patients with AV conduction abnormalities.
    • Diltiazem: Useful for Prinzmetal angina, but with caution in heart failure due to negative inotropic effects.
Nitrates
  • Help relieve angina by relaxing vascular smooth muscle, reducing myocardial oxygen demand and increasing blood supply.
  • Nitroglycerin (NTG) offers quick relief for angina.
  • Caution with tolerance build-up; manage by implementing nitrate-free intervals.
Sodium Channel Blockers (Ranolazine)
  • Helps manage angina by improving oxygen supply and demand.
  • Can have QT interval prolongation and interactions with other drugs, requiring careful monitoring during therapy.
  • Antianginal efficacy may be less pronounced in women, highlighting the need for personalized treatment strategies.